Asia Pacific Next Generation Antibody Market

Home Healthcare And Pharmaceutical Asia Pacific Next Generation Antibody Market

SPECIAL OFFER : 25% Super Discount For All !

Asia Pacific Next Generation Antibody Market, By Therapeutic Area (Oncology, Autoimmune/Inflammatory); By Technology (Antibody-Drug Conjugates (ADC's), Bispecific Antibodies, FC Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, Biosimilar Antibody Products); By Country (China, India, Japan, South Korea, Indonesia, Vietnam, Malaysia, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2030

Published Date: January 2024
Report ID: BWC24052
Available Format: PDF
Page: 200

Report Overview

A growing demand for targeted therapies, increasing investments in biotechnology research, rising prevalence of chronic diseases, and advancements in antibody technology are key driving factors propelling the growth of the Asia Pacific Next Generation Antibody Market during the forecast period between 2024 and 2030.

Asia Pacific Next Generation Antibody Market – Industry Trends & Forecast Report, 2030

The Asia Pacific Next Generation Antibody Market size was estimated at USD 1,024.31 million in 2023. During the forecast period between 2024 and 2029, the size of Asia Pacific Next Generation Antibody Market is projected to grow at a CAGR of 12.36% reaching a value of USD 2,061.23 million by 2030. The Asia Pacific Next Generation Antibody Market is propelled by a rising demand for targeted therapies, advancements in biotechnology, and increasing prevalence of chronic diseases. Collaborations between pharmaceutical companies and research institutions, along with growing investments in research and development, contribute to market expansion. Additionally, the region's supportive regulatory environment and a burgeoning biopharmaceutical industry further drive innovations in next generation antibody therapies. The rising adoption of personalized medicine and the quest for more effective and safer treatment options enhance the market growth, positioning the Asia Pacific region as a key player in the development and commercialization of next generation antibodies.

Asia Pacific Next Generation Antibody Market

Next Generation Antibody – Overview

Next generation antibodies represent an advanced class of therapeutic proteins designed to enhance traditional antibody capabilities. Engineered for improved target specificity, binding affinity, and reduced side effects, they often incorporate novel formats such as bispecific or multi-specific antibodies. Additionally, advancements in technologies like phage display, transgenic animals, and computational modeling contribute to their development. The antibodies hold significant promise in treating various diseases, including cancer and autoimmune disorders, offering more precise and potent therapeutic options compared to conventional antibodies. The innovative design aims to address challenges and enhance therapeutic efficacy in diverse medical applications.

Asia Pacific Next Generation Antibody Market

Growth Drivers

Escalating Incidence of Chronic Diseases

In an era marked by a rising prevalence of chronic diseases across the Asia Pacific region, the Next Generation Antibody Market is experiencing unprecedented growth. The surge is attributed to the pressing need for advanced therapeutic solutions, propelling the market to new heights. As the healthcare landscape evolves to combat complex diseases, the demand for innovative antibody therapies continues to skyrocket, positioning the Asia Pacific market as a pivotal player in the global biopharmaceutical landscape.

Challenges

Innovative Solutions Needed to Address Soaring Expenses

The Asia Pacific Next Generation Antibody Market grapples with the formidable challenge of high costs linked to development and manufacturing. The financial burden, encompassing research, clinical trials, and production expenses, poses a significant barrier to market growth. Stakeholders must explore creative and cost-effective strategies to navigate the restraint, fostering collaborations, leveraging technology, and implementing efficient production methods to propel the market forward in the face of financial challenges.

Impact of Escalating Geopolitical Tensions on Asia Pacific Next Generation Antibody Market

The Asia Pacific Next Generation Antibody Market is significantly influenced by escalating geopolitical tensions, particularly involving major players such as China, the United States, and neighboring nations. This complex geopolitical dynamic creates a ripple effect on the antibody market, impacting trade restrictions, export controls, and international relations. The resulting disruptions in the supply chain for next generation antibody-related products, coupled with regulatory hurdles and political uncertainties, pose challenges to collaborative research efforts and hinder the flow of crucial information for innovation in antibody development. Geopolitical tensions may also prompt shifts in research and development investments, leading to disparities in technological advancements and market growth among nations in the region. Additionally, the tensions could affect the regulatory environment, potentially altering approval processes for next generation antibody therapies and requiring companies to adapt their strategic plans. The market's overall progress is intricately linked to geopolitical realities, and any escalation in tensions has the potential to reshape the landscape significantly.

Asia Pacific Next Generation Antibody Market

Segmental Coverage

Asia Pacific Next Generation Antibody Market – By Therapeutic Area

Based on therapeutic area, Asia Pacific Next Generation Antibody Market is divided into Oncology and Autoimmune/Inflammatory segments. The oncology segment is a larger therapeutic area in the market. Both oncology and autoimmune/inflammatory segments represent critical areas in the region's healthcare landscape, reflecting the demand for advanced antibody therapies to address diverse medical challenges. The market's focus on oncology highlights a commitment to advancing cancer treatment, while the autoimmune/inflammatory segment underscores the importance of addressing conditions related to the immune system. Together, the segments signify the growing significance of next generation antibody solutions in tackling major health concerns across the Asia Pacific region

Asia Pacific Next Generation Antibody Market – By Technology

Based on technology, Asia Pacific Next Generation Antibody Market is divided into Antibody-Drug Conjugates (ADCs), Bispecific Antibodies, FC Engineered Antibodies, Antibody Fragments & Antibody-like Proteins, and Biosimilar Antibody product segments. The antibody-drug conjugates (ADCs) segment is the largest technology in the Asia Pacific Next Generation Antibody Market. The innovative segment combines monoclonal antibodies with cytotoxic drugs, targeting specific cancer cells while minimizing damage to healthy cells. ADCs represent a significant advancement in cancer treatment, contributing to the market's growth. Other segments, such as bispecific antibodies, FC-engineered antibodies, antibody fragments, antibody-like proteins, and biosimilar antibody products, also play crucial roles in shaping the market landscape and addressing diverse therapeutic needs. However, ADCs stand out as the dominant and impactful segment in the dynamic landscape of next generation antibody development in the Asia Pacific region.

Asia Pacific Next Generation Antibody Market Share

Asia Pacific Next Generation Antibody Market – By Country

Based on country, Asia Pacific Next Generation Antibody Market is divided into China, India, Japan, South Korea, Indonesia, Vietnam, Malaysia, and Rest of Asia Pacific. China holds the largest market share, exhibiting substantial growth in the next generation antibody market. The country's increasing investments in research and development, coupled with a growing demand for advanced therapeutic antibodies, contribute significantly to its dominant position in the regional market. This underscores China's pivotal role in shaping the future landscape of next generation antibody advancements in the Asia Pacific region.

Competitive Landscape

Major players in the Asia Pacific Next Generation Antibody Market include F. Hoffmann-La Roche Ltd, Kyowa Kirin Co., Ltd, Seagen Inc., ImmunoGen, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., and Pfizer Inc. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Asia Pacific Next Generation Antibody Market.

Recent Developments

In July 2021 - Roche announced that Japan's Ministry of Health, Labour and Welfare (MHLW) had approved Ronapreve (casirivimab and imdevimab) to treat patients with mild to moderate COVID-19 via intravenous infusion.
In December 2020 - CEPI, the Coalition for Epidemic Preparedness Innovations, announced a collaboration with South Korea-based SK Bioscience to advance the development of a next generation vaccine against SARS-CoV-2, the virus that causes COVID-19.

Scope of Report

Attributes	Details
Years Considered	Historical Data – 2019–2023
	Base Year – 2023
	Estimated Year – 2024
	Forecast Period – 2024–2030
Facts Covered	Revenue in USD Million
Market Coverage	China, India, Japan, South Korea, Indonesia, Vietnam, Malaysia, Rest of Asia Pacific
Product/Service Segmentation	Therapeutic Area, Technology, Country
Key Players	F. Hoffmann-La Roche Ltd, Kyowa Kirin Co., Ltd, Seagen Inc., ImmunoGen, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Pfizer Inc.

By Therapeutic Area

Oncology
Autoimmune/Inflammatory

By Technology

Antibody-Drug Conjugates (ADC's)
Bispecific Antibodies
FC Engineered Antibodies
Antibody Fragments & Antibody-like Proteins
Biosimilar Antibody Products

By Country

China
India
Japan
South Korea
Indonesia
Vietnam
Malaysia
Rest of Asia Pacific

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Executive Summary
Asia Pacific Next Generation Antibody Market Insights
1. Industry Value Chain Analysis
  1. DROC Analysis
  2. Growth Drivers
    1. The rising prevalence of chronic diseases
    2. Increasing investment in antibody research and development
  3. Restraints
    1. High costs associated with development and manufacturing
  4. Opportunities
    1. Advancement in technology
  5. Challenges
    1. Complex regulatory environment
2. Technological Advancements/Recent Developments
3. Regulatory Framework
4. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Asia Pacific Next Generation Antibody Market Overview
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapeutic Area
    1. Oncology
    2. Autoimmune/Inflammatory
  2. By Technology
    1. Antibody-Drug Conjugates (ADC's)
    2. Bispecific Antibodies
    3. FC Engineered Antibodies
    4. Antibody Fragments and Antibody-like Proteins
    5. Biosimilar Antibody Products
  3. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Indonesia
    6. Vietnam
    7. Malaysia
    8. Rest of Asia Pacific
China Next Generation Antibody Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapeutic Area
  2. By Technology
India Next Generation Antibody Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapeutic Area
  2. By Technology
Japan Next Generation Antibody Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapeutic Area
  2. By Technology
South Korea Next Generation Antibody Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapeutic Area
  2. By Technology
Indonesia Next Generation Antibody Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapeutic Area
  2. By Technology
Vietnam Next Generation Antibody Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapeutic Area
  2. By Technology
Malaysia Next Generation Antibody Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapeutic Area
  2. By Technology
Rest of Asia Pacific Next Generation Antibody Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Therapeutic Area
  2. By Technology
Competitive Landscape
1. List of Key Players and Their Offerings
2. Asia Pacific Next Generation Antibody Company Market Share Analysis, 2023
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
Impact of Escalating Geopolitical Tensions on Asia Pacific Next Generation Antibody Market
Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
1. F. Hoffmann-La Roche Ltd
2. Kyowa Kirin Co., Ltd
3. Seagen Inc.
4. ImmunoGen, Inc.
5. Takeda Pharmaceutical Company Limited
6. Amgen Inc.
7. Pfizer Inc.
8. Other Prominent Players
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1 Asia Pacific Next Generation Antibody Segmentation

Figure 2 Asia Pacific Next Generation Antibody Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2023

Figure 4 Asia Pacific Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Figure 5 Asia Pacific Next Generation Antibody Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 6 Asia Pacific Next Generation Antibody Market Share, By Technology, By Value, 2019–2030

Figure 7 Asia Pacific Next Generation Antibody Market Share, By Country, By Value, 2019–2030

Figure 8 China Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Figure 9 China Next Generation Antibody Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 10 China Next Generation Antibody Market Share, By Technology, By Value, 2019–2030

Figure 11 India Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Figure 12 India Next Generation Antibody Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 13 India Next Generation Antibody Market Share, By Technology, By Value, 2019–2030

Figure 14 Japan Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Figure 15 Japan Next Generation Antibody Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 16 Japan Next Generation Antibody Market Share, By Technology, By Value, 2019–2030

Figure 17 South Korea Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Figure 18 South Korea Next Generation Antibody Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 19 South Korea Next Generation Antibody Market Share, By Technology, By Value, 2019–2030

Figure 20 Australia & New Zealand Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Figure 21 Australia & New Zealand Next Generation Antibody Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 22 Australia & New Zealand Next Generation Antibody Market Share, By Technology, By Value, 2019–2030

Figure 23 Indonesia Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Figure 24 Indonesia Next Generation Antibody Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 25 Indonesia Next Generation Antibody Market Share, By Technology, By Value, 2019–2030

Figure 26 Malaysia Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Figure 27 Malaysia Next Generation Antibody Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 28 Malaysia Next Generation Antibody Market Share, By Technology, By Value, 2019–2030

Figure 29 Singapore Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Figure 30 Singapore Next Generation Antibody Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 31 Singapore Next Generation Antibody Market Share, By Technology, By Value, 2019–2030

Figure 32 Vietnam Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Figure 33 Vietnam Next Generation Antibody Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 34 Vietnam Next Generation Antibody Market Share, By Technology, By Value, 2019–2030

Figure 35 Rest of APAC Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Figure 36 Rest of APAC Next Generation Antibody Market Share, By Therapeutic Area, By Value, 2019–2030

Figure 37 Rest of APAC Next Generation Antibody Market Share, By Technology, By Value, 2019–2030

List of Tables

Table 1 Asia Pacific Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Table 2 Asia Pacific Next Generation Antibody Market Size, By Therapeutic Area, By Value, 2019–2030

Table 3 Asia Pacific Next Generation Antibody Market Size, By Technology, By Value, 2019–2030

Table 4 Asia Pacific Next Generation Antibody Market Size, By Country, By Value, 2019–2030

Table 5 China Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Table 6 China Next Generation Antibody Market Size, By Therapeutic Area, By Value, 2019–2030

Table 7 China Next Generation Antibody Market Size, By Technology, By Value, 2019–2030

Table 8 India Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Table 9 India Next Generation Antibody Market Size, By Therapeutic Area, By Value, 2019–2030

Table 10 India Next Generation Antibody Market Size, By Technology, By Value, 2019–2030

Table 11 Japan Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Table 12 Japan Next Generation Antibody Market Size, By Therapeutic Area, By Value, 2019–2030

Table 13 Japan Next Generation Antibody Market Size, By Technology, By Value, 2019–2030

Table 14 South Korea Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Table 15 South Korea Next Generation Antibody Market Size, By Therapeutic Area, By Value, 2019–2030

Table 16 South Korea Next Generation Antibody Market Size, By Technology, By Value, 2019–2030

Table 17 Australia & New Zealand Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Table 18 Australia & New Zealand Next Generation Antibody Market Size, By Therapeutic Area, By Value, 2019–2030

Table 19 Australia & New Zealand Next Generation Antibody Market Size, By Technology, By Value, 2019–2030

Table 20 Indonesia Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Table 21 Indonesia Next Generation Antibody Market Size, By Therapeutic Area, By Value, 2019–2030

Table 22 Indonesia Next Generation Antibody Market Size, By Technology, By Value, 2019–2030

Table 23 Malaysia Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Table 24 Malaysia Next Generation Antibody Market Size, By Therapeutic Area, By Value, 2019–2030

Table 25 Malaysia Next Generation Antibody Market Size, By Technology, By Value, 2019–2030

Table 26 Singapore Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Table 27 Singapore Next Generation Antibody Market Size, By Therapeutic Area, By Value, 2019–2030

Table 28 Singapore Next Generation Antibody Market Size, By Technology, By Value, 2019–2030

Table 29 Vietnam Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Table 30 Vietnam Next Generation Antibody Market Size, By Therapeutic Area, By Value, 2019–2030

Table 31 Vietnam Next Generation Antibody Market Size, By Technology, By Value, 2019–2030

Table 32 Rest of APAC Next Generation Antibody Market Size, By Value (USD Million), 2019–2030

Table 33 Rest of APAC Next Generation Antibody Market Size, By Therapeutic Area, By Value, 2019–2030

Table 34 Rest of APAC Next Generation Antibody Market Size, By Technology, By Value, 2019–2030

Table 35 F. Hoffmann-La Roche Ltd Generation Company Overview

Table 36 F. Hoffmann-La Roche Ltd Generation Financial Overview

Table 37 Kyowa Kirin Co., Ltd Company Overview

Table 38 Kyowa Kirin Co., Ltd Financial Overview

Table 39 Seagen Inc. Company Overview

Table 40 Seagen Inc. Financial Overview

Table 41 ImmunoGen, Inc. Company Overview

Table 42 ImmunoGen, Inc. Financial Overview

Table 43 Takeda Pharmaceutical Company Limited Company Overview

Table 44 Takeda Pharmaceutical Company Limited Financial Overview

Table 45 Amgen Inc. Company Overview

Table 46 Amgen Inc. Financial Overview

Table 47 Pfizer Inc. Company Overview

Table 48 Pfizer Inc. Financial Overview

Market Segmentation

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. What is the current market size of Asia Pacific Next Generation Antibody Market?

Ans: Asia Pacific Next Generation Antibody Market size was estimated at USD 1,024.31 million in 2023.

2. What is the expected CAGR of Asia Pacific Next Generation Antibody Market during the forecast period?

Ans: Asia Pacific Next Generation Antibody Market size is expected to grow at a CAGR of 12.36% during the forecast period between 2024 and 2030.

3. What is the forecast value of the Asia Pacific Next Generation Antibody Market size by 2030?

Ans: Asia Pacific Next Generation Antibody Market size is expected to reach a value of USD 2,061.23 million by 2030.

4. What are the major factors driving the growth of Asia Pacific Next Generation Antibody Market?

Ans: Major factors driving the growth of the Asia Pacific Next Generation Antibody Market include a growing demand for targeted therapies, increasing investment in biotechnology research, rising prevalence of chronic diseases, and advancements in antibody technology.

PLACE AN ORDER

SINGLE USER LICENSE
$ 2699.25 ~~$ 3599~~
GROUP LICENSE
$ 3000 ~~$ 4000~~
ENTERPRISE LICENSE
$ 3375 ~~$ 4500~~
EXCEL DATA PACK
$ 1575 ~~$ 2100~~

ENQUIRE BEFORE PURCHASE

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.

Asia Pacific Next Generation Antibody Market

Asia Pacific Next Generation Antibody Market

Report Overview

Market Segmentation

To request a free sample copy of this report, please complete the form below.

Frequently Asked Questions (FAQs):

1. What is the current market size of Asia Pacific Next Generation Antibody Market?

2. What is the expected CAGR of Asia Pacific Next Generation Antibody Market during the forecast period?

3. What is the forecast value of the Asia Pacific Next Generation Antibody Market size by 2030?

4. What are the major factors driving the growth of Asia Pacific Next Generation Antibody Market?

5. Which country holds the highest market share in the Asia Pacific Next Generation Antibody Market?

6. Which is the leading technology segment in Asia Pacific Next Generation Antibody Market?

7. Name the key players in Asia Pacific Next Generation Antibody Market.

PLACE AN ORDER

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Custom Research Service

Quality & Accuracy

Data Visualization

Information security